How Shares Look in the Eyes of Analysts: Baidu, Inc. (NASDAQ:BIDU), Johnson & Johnson (NYSE:JNJ)

In the most recent session, Baidu, Inc. (NASDAQ:BIDU) shares have traded +0.63%. Following the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent review, the stock has been noted $0.53 away from the 50-day moving average of $175.58 and $1.81 away from the 200-day moving average of $174.30. From a different angle, the stock has been recently recorded -12.38% off of the 52-week high of 201.00 and +13.41% removed from the 52-week low of 155.28. 

Currently, Baidu, Inc. has a price to earnings ratio of 38.06. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio below one, it may be viewed as undervalued. If a company has a PEG Ratio above one, it may show that the company is overvalued. A PEG Ratio near one may be viewed as fair value. The stock currently has a PEG Ratio of 73.85.

Price Target Update

Analysts polled by Thomson Reuters have set a consensus target price of $195.61 on shares. Target prices may vary from one analyst to another due to the various ways they may proceed to calculate future price targets. This is a near-term estimation for the next 12-18 months.

For the current quarter, analysts are expecting Johnson & Johnson (NYSE:JNJ) to report EPS of $1.76. This consensus estimate is provided by Zacks Research. After the period that ended on 2016-12-31, Johnson & Johnson (NYSE:JNJ) reported an EPS actual of $1.58. The difference between the actual and estimate resulted in a surprise factor of 1.28%. The company is expected to release their next earnings report on or around 2017-04-18. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Johnson & Johnson (NYSE:JNJ) have a current ABR or average broker rating of 2.22. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Johnson & Johnson (NYSE:JNJ) is $125.733. The top analyst target is $150, and the lowest target is $81 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Comment